Przemysław Dutka

Przemysław Dutka

Auto-generated profile, based on publicly available information

Przemysław Dutka

Division of Biology and Biological Engineering, California Institute of Technology

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SMSomnath Mukherjee
Somnath Mukherjee
SESatchal K. Erramilli
Satchal K. Erramilli
MAMark Ammirati
Mark Ammirati
FAFrances J. D. Alvarez
Frances J. D. Alvarez
KFKimberly F. Fennell
Kimberly F. Fennell
AKAnthony A. Kossiakoff
Anthony A. Kossiakoff
We propose the concept of universal fiducials based on a set of pre-made semi-synthetic antibodies (sABs) generated by customized phage display selections against the fusion protein BRIL, an engineered variant of apocytochrome b562a. These sABs can bind to BRIL fused either into the loops or termini of different GPCRs, ion channels, receptors and transporters without disrupting their structure. A crystal structure of BRIL in complex with an affinity-matured sAB (BAG2) that bound to all systems tested delineates the footprint of interaction. Negative stain and cryoEM data of several examples of BRIL-membrane protein chimera highlight the effectiveness of the sABs as universal fiducial marks. Taken together with a cryoEM structure of sAB bound human nicotinic acetylcholine receptor, this work demonstrates that these anti-BRIL sABs can greatly enhance the particle properties leading to improved cryoEM outcomes, especially for challenging membrane proteins.

27 February 2021 in Protein Science
Verified
Journal Article
Closed access
PDF file
PDPrzemysław Dutka
Przemysław Dutka
DMDina Malounda
Dina Malounda
LMLauren Ann Metskas
Lauren Ann Metskas
SCSongye Chen
Songye Chen
RHRobert C. Hurt
Robert C. Hurt
MSMikhail G. Shapiro
Mikhail G. Shapiro

15 March 2024 in Advanced Materials
Verified
Journal Article
Open access
BLBill Ling
Bill Ling
BGBilge Gungoren
Bilge Gungoren
YYYuxing Yao
Yuxing Yao
PDPrzemysław Dutka
Przemysław Dutka
RVReid Vassallo
Reid Vassallo
MSMikhail G. Shapiro
Mikhail G. Shapiro
Nanotechnology offers significant advantages for medical imaging and therapy, including enhanced contrast and precision targeting. However, integrating these benefits into ultrasonography is challenging due to the size and stability constraints of conventional bubble‐based agents. Here bicones, truly tiny acoustic contrast agents based on gas vesicles (GVs), a unique class of air‐filled protein nanostructures naturally produced in buoyant microbes, are described. It is shown that these sub‐80 nm particles can be effectively detected both in vitro and in vivo, infiltrate tumors via leaky vasculature, deliver potent mechanical effects through ultrasound‐induced inertial cavitation, and are easily engineered for molecular targeting, prolonged circulation time, and payload conjugation.

12 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
ZJZhiyang Jin
Zhiyang Jin
ALAnupama Lakshmanan
Anupama Lakshmanan
RZRuby Zhang
Ruby Zhang
TTTeresa A. Tran
Teresa A. Tran
CRClaire Rabut
Claire Rabut
MSMikhail G. Shapiro
Mikhail G. Shapiro
Calcium imaging has enabled major biological discoveries. However, the scattering of light by tissue limits the use of standard fluorescent calcium indicators in living animals. To address this limitation, we introduce the first genetically encoded ultrasonic reporter of calcium (URoC). Based on a unique class of air-filled protein nanostructures called gas vesicles, we engineered URoC to produce elevated nonlinear ultrasound signal upon binding to calcium ions. With URoC expressed in mammalian cells, we demonstrate noninvasive ultrasound imaging of calcium signaling in vivo during drug-induced receptor activation. URoC brings the depth and resolution advantages of ultrasound to the in vivo imaging of dynamic cellular function and paves the way for acoustic biosensing of a broader variety of biological signals.

22 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
PDPrzemysław Dutka
Przemysław Dutka
YLYuxi Liu
Yuxi Liu
SMStefano Maggi
Stefano Maggi
DGDebnath Ghosal
Debnath Ghosal
JWJue Wang
Jue Wang
GJGrant Jensen
Grant Jensen
The Legionella pneumophila Dot/Icm type IV secretion system (T4SS) delivers effector proteins into host cells during infection. Despite its significance as a potential drug target, our current understanding of its atomic structure is limited to isolated subcomplexes. In this study, we used subtomogram averaging and integrative modeling to construct a nearly-complete model of the Dot/Icm T4SS accounting for seventeen protein components. We locate and provide insights into the structure and function of six new components including DotI, DotJ, DotU, IcmF, IcmT, and IcmX. We find that the cytosolic N-terminal domain of IcmF, a key protein forming a central hollow cylinder, interacts with DotU, providing insight into previously uncharacterized density. Furthermore, our model, in combination with analyses of compositional heterogeneity, explains how the cytoplasmic ATPase DotO is connected to the periplasmic complex via interactions with membrane-bound DotI/DotJ proteins. Coupled with in situ infection data, our model offers new insights into the T4SS-mediated secretion mechanism.

27 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRobert C. Hurt
Robert C. Hurt
MBMarjorie T. Buss
Marjorie T. Buss
MDMengtong Duan
Mengtong Duan
KWKatie Wong
Katie Wong
MYMei Yi You
Mei Yi You
MSMikhail G. Shapiro
Mikhail G. Shapiro
A major outstanding challenge in the fields of biological research, synthetic biology and cell-based medicine is visualizing the function of natural and engineered cells noninvasively inside opaque organisms. Ultrasound imaging has the potential to address this challenge as a widely available technique with a tissue penetration of several centimeters and spatial resolution below 100 μm. Recently, the first genetically encoded acoustic reporters were developed based on bacterial gas vesicles to link ultrasound signals to molecular and cellular function. However, the properties of these first-generation acoustic reporter genes (ARGs) resulted in limited sensitivity and specificity for imaging gene expression in vivo. Here, we describe second-generation ARGs with greatly improved acoustic properties and expression characteristics, identified through a phylogenetic screen of candidate gene clusters from diverse bacteria and archaea. The resulting constructs offer major qualitative and quantitative improvements, including much stronger ultrasound contrast, the ability to produce nonlinear signals distinguishable from background tissue, and stable long-term expression. We demonstrate the capabilities of these next-generation ARGs by imaging in situ gene expression in mouse models of breast cancer and tumor-homing therapeutic bacteria, noninvasively revealing the unique spatial distributions of tumor growth and colonization by therapeutic cells in living subjects and providing real-time guidance for interventions such as needle biopsies.